Lotus Eye Valuation
| LOTUSEYE | 68.43 7.60 12.49% |
At this time, the firm appears to be overvalued. Lotus Eye Hospital secures a last-minute Real Value of USD55.88 per share. The latest price of the firm is USD68.43. Our model forecasts the value of Lotus Eye Hospital from analyzing the firm fundamentals such as Current Valuation of 1.23 B, return on equity of 0.0498, and Profit Margin of 0.01 % as well as examining its technical indicators and probability of bankruptcy.
Price Book 2.1047 | Enterprise Value 1.2 B | Enterprise Value Ebitda 22.2418 | Price Sales 2.9082 | Trailing PE 285.125 |
Overvalued
Today
Please note that Lotus Eye's price fluctuation is very steady at this time. Calculation of the real value of Lotus Eye Hospital is based on 3 months time horizon. Increasing Lotus Eye's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Lotus Eye is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Lotus Stock. However, Lotus Eye's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 68.43 | Real 55.88 | Hype 68.73 |
The intrinsic value of Lotus Eye's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Lotus Eye's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Lotus Eye Hospital helps investors to forecast how Lotus stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Lotus Eye more accurately as focusing exclusively on Lotus Eye's fundamentals will not take into account other important factors: Lotus Eye Cash |
|
Lotus Eye Total Value Analysis
Lotus Eye Hospital is now forecasted to have takeover price of 1.23 B with market capitalization of 1.42 B, debt of 11.1 M, and cash on hands of 36.03 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Lotus Eye fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.23 B | 1.42 B | 11.1 M | 36.03 M |
Lotus Eye Investor Information
About 65.0% of the company outstanding shares are owned by corporate insiders. The book value of Lotus Eye was now reported as 29.26. The company last dividend was issued on the 18th of September 2023. Based on the measurements of operating efficiency obtained from Lotus Eye's historical financial statements, Lotus Eye Hospital is performing exceptionally good at this time. It has a great probability to report excellent financial results in April.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total Cash From Operating Activities | 43.3 M | 65.4 M |
|
|
Lotus Eye Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Lotus Eye has an asset utilization ratio of 72.36 percent. This suggests that the Company is making USD0.72 for each dollar of assets. An increasing asset utilization means that Lotus Eye Hospital is more efficient with each dollar of assets it utilizes for everyday operations.Lotus Eye Ownership Allocation
Lotus Eye Hospital maintains a total of 20.8 Million outstanding shares. Lotus Eye Hospital secures majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 64.6 % of Lotus Eye Hospital outstanding shares that are owned by insiders conveys that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Lotus Eye Profitability Analysis
The company reported the revenue of 482.1 M. Net Income was 29.14 M with profit before overhead, payroll, taxes, and interest of 116.89 M.About Lotus Eye Valuation
Our relative valuation model uses a comparative analysis of Lotus Eye. We calculate exposure to Lotus Eye's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Lotus Eye's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 156 M | 185.1 M |
Lotus Eye Quarterly Retained Earnings |
|
Additional Tools for Lotus Stock Analysis
When running Lotus Eye's price analysis, check to measure Lotus Eye's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lotus Eye is operating at the current time. Most of Lotus Eye's value examination focuses on studying past and present price action to predict the probability of Lotus Eye's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lotus Eye's price. Additionally, you may evaluate how the addition of Lotus Eye to your portfolios can decrease your overall portfolio volatility.